- Home
- PYPD vs OKYO Comparison
PYPD vs OKYO Comparison
Compare PYPD & OKYO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PYPD
- OKYO
- Stock Information
- Founded
- PYPD 2008
- OKYO 2007
- Country
- PYPD Israel
- OKYO United Kingdom
- Employees
- PYPD N/A
- OKYO N/A
- Industry
- PYPD Medical/Dental Instruments
- OKYO Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- PYPD Health Care
- OKYO Health Care
- Exchange
- PYPD Nasdaq
- OKYO Nasdaq
- Market Cap
- PYPD 35.3M
- OKYO 37.0M
- IPO Year
- PYPD 2020
- OKYO 2022
- Fundamental
- Price
- PYPD $3.58
- OKYO $2.43
- Analyst Decision
- PYPD Strong Buy
- OKYO Strong Buy
- Analyst Count
- PYPD 5
- OKYO 1
- Target Price
- PYPD $11.40
- OKYO $7.00
- AVG Volume (30 Days)
- PYPD 1.4M
- OKYO 213.3K
- Earning Date
- PYPD 08-13-2025
- OKYO 08-12-2025
- Dividend Yield
- PYPD N/A
- OKYO N/A
- EPS Growth
- PYPD N/A
- OKYO N/A
- EPS
- PYPD N/A
- OKYO N/A
- Revenue
- PYPD N/A
- OKYO N/A
- Revenue This Year
- PYPD N/A
- OKYO N/A
- Revenue Next Year
- PYPD N/A
- OKYO N/A
- P/E Ratio
- PYPD N/A
- OKYO N/A
- Revenue Growth
- PYPD N/A
- OKYO N/A
- 52 Week Low
- PYPD $2.30
- OKYO $0.81
- 52 Week High
- PYPD $4.49
- OKYO $3.11
- Technical
- Relative Strength Index (RSI)
- PYPD 59.00
- OKYO 58.47
- Support Level
- PYPD $3.12
- OKYO $2.05
- Resistance Level
- PYPD $3.75
- OKYO $2.56
- Average True Range (ATR)
- PYPD 0.29
- OKYO 0.32
- MACD
- PYPD 0.01
- OKYO -0.01
- Stochastic Oscillator
- PYPD 69.83
- OKYO 48.50
About PYPD PolyPid Ltd.
PolyPid Ltd is a clinical-stage biopharmaceutical company engaged in the research and development of products based on PLEX (Polymer-Lipid Encapsulation MatriX), the company's proprietary drug delivery technology. PLEX is capable of encapsulating many types of drugs to enable targeted, localized drug delivery into the body over extended periods of time with pre-determined release rates thus optimizing drug treatment regimens. BonyPid, PolyPid, Opzifend, Ssisurg, Elyfssi, Baczenssi, Opzifend and Bacyssio are trademarks of the company. Its product candidate include D-PLEX100 for prevention of SSI in soft tissue and OncoPLEX which can be a potential Intra-tumoral therapy.
About OKYO OKYO Pharma Limited
OKYO Pharma Ltd is a biopharmaceutical company. The company is developing therapeutics to improve the lives of patients with inflammatory eye diseases and chronic pain. It offers solutions for various diseases such as Dry Eye Disease, Non-infectious Anterior Uveitis, Allergenic Conjunctivitis, Chronic Pain, and Ocular Pain.